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Traumatic brain injury (TBI) is a serious public health concern which strikes someone every
15 s on average in the US. Even mild TBI, which comprise as many as 75% of all TBI
cases, carries long term consequences. The effects of age and sex on long term outcome
from TBI is not fully understood, but due to the increased risk for neurodegenerative
diseases after TBI it is important to understand how these factors influence the outcome
from TBI. This study examined the neurobehavioral and neuropathological effects of age
and sex on the outcome 15 days following repetitive mild traumatic brain injury (r-mTBI) in
mice transgenic for human tau (hTau). These mice express the six human isoforms of tau
but do not express endogenous murine tau and they develop tau pathology and memory
impairment in an age-dependent manner. After 5mild impacts, aged femalemice showed
motor impairments that were absent in aged male mice, as well as younger animals.
Conversely, aged female sham mice outperformed all other groups of aged mice in a
Barnes maze spatial memory test. Pathologically, increases in IBA-1 and GFAP staining
typically seen in this model of r-mTBI showed the expected increases with both injury
and age, but phosphorylated tau stained with CP13 in the hippocampus (reduced in
female sham mice compared to males) and PHF1 in the cortex (reduced in female TBI
mice compared to male TBI mice) showed the only histological signs of sex-dependent
differences in these mice.
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INTRODUCTION
Traumatic brain injury (TBI) contributes to in excess of 2.5 million emergency department visits a
year in the United States (CDC), with a 70% increase in attendances from 2001 to 2010 (Faul et al.,
2010). Notably, there is a distinct sex bias in TBI presentations, with themajority of hospitalized TBI
occurring in women (National Hospital Discharge Survey 2001–2010), particularly in the elderly
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(Stevens and Sogolow, 2005). In a meta-analysis of the influence
of sex on TBI it was reported that, compared to men, women
display worse outcomes from TBI across multiple measures,
including mortality, days of post-traumatic amnesia, memory
impairment, and insomnia (Farace and Alves, 2000), with one
study of 306 individuals with a history of moderate to severe TBI
documenting an increased incidence of self-reported headaches,
dizziness, and depression in women with a history of TBI
(Colantonio et al., 2010). Nevertheless, despite this bias, there
has been limited enquiry into the influence of sex on acute or
long-term consequences of TBI.
Pre-clinical research has not yet addressed potential sex-
dependent differences and typically focuses on TBI in male
subjects. Treatments that may be beneficial in one sex may not
benefit males and females equally, or may be modulated by
additional factors that need to be understood prior to attempting
clinical translation. For example, environmental enrichment has
been studied for its potential therapeutic benefit following TBI
in rats since 1996, but until 2002 these studies were performed
exclusively with male animals (Hamm et al., 1996). In 2002, a
study by Wagner and colleagues demonstrated a beneficial effect
of environmental enrichment in male rats which did not occur
when female rats were utilized (Wagner et al., 2002). However,
when the rotarod testing was performed to assay the effects
of environmental enrichment, benefits were seen in both male
and female rats after controlled cortical impact (Monaco et al.,
2013). These results highlight the importance of understanding
the differences between TBI recovery and outcome in male
and female animals as these effects may impact the efficacy of
experimental treatments following TBI.
The mechanisms by which sex differences influence outcome
from TBI and the response to TBI treatments has not been well-
studied, though studies have examined the possibility of using
exogenously administered gonadal steroids as a treatment for
TBI. Based on some preliminary data showing better outcome in
females after TBI, a number of studies have examined potential
neuroprotective effects of female sex hormone administration
on the consequences of experimentally induced TBI (Behl et al.,
1995; Pelligrino et al., 1998; Shi et al., 1998; Behl, 2002; Wagner
et al., 2004; Xiong et al., 2007). Pre-clinical studies have shown
that progesterone reduces cerebral edema (Roof et al., 1992, 1994;
Wright et al., 2001; Guo et al., 2006) and estrogen maintains
cerebral blood flow after experimental TBI (Roof and Hall,
2000a), but despite these pre-clinical protective effects, attempts
to translate these results into human clinical trials have not been
successful (Skolnick et al., 2014; Howard et al., 2016; Schumacher
et al., 2016).
The disconnection between pre-clinical neuroprotective
effects of female sex hormones, and their translation to clinical
trials in humans may be due in part to an insufficient
understanding of the role of sex in TBI and how it interacts
with other biological factors such as age. For example, in clinical
trials testing progesterone administration after TBI, the inclusion
criteria for each trial involved patients spanning a very wide range
of age at TBI of 18–60 years of age or more, and heterogeneity of
the patient population of these studies has been cited as a concern
for the ability of the trial design to yield relevant results (Ma et al.,
2012). Both pre-clinical research in animals and clinical research
in humans have shown an age-related risk for neurodegenerative
disorders and a linear increase in the risk of mortality and poor
outcome following TBI, but the mechanisms by which age at the
time of TBI plays a role in influencing outcome fromTBI have not
been elucidated and age remains an under-studied factor in TBI
(Hukkelhoven et al., 2003; Uryu et al., 2003; Stocchetti et al., 2012;
Gardner et al., 2014).Women are known to be disproportionately
represented in Alzheimer’s disease (AD) patient populations,
where they comprise approximately two thirds of the AD patient
population in the United States (Brookmeyer et al., 1998). In
contrast to this, there are very few reports in the literature of
chronic traumatic encephalopathy (CTE) in women (Roberts
et al., 1990; Hof et al., 1991). This may be a selection bias as most
of the donated brains have been frommales, but more research is
needed to rule out the possibility of a sex-dependent effect on the
risk for developing CTE.
In the current study, we utilize our preclinical mouse model of
repetitive mild TBI (Mouzon et al., 2012, 2014; Ojo et al., 2013)
to study the roles of age and sex on behavioral and pathological
outcomes after repetitive mild brain injury. We have conducted
these studies in mice transgenic for all six isoforms of human tau
protein (hTau). Tau pathology has been documented in brain of
humans after severe TBI and in sport athletes who sustained a
number of concussions/mild TBI resulting in CTE, (McKee et al.,
2009) and as the precise role of tau in TBI pathogenesis is not yet
clear we wanted to mimic human patients as closely as possible
with our model. Moreover, the interaction of sex and age with
tau pathology after TBI is an area that has not been investigated
before, although Tau aggregation after TBI is associated with
impaired glymphatic function, which also reduces with age (Iliff
et al., 2014; Kress et al., 2014). Since the role and interaction
of sex and age on TBI has not been thoroughly investigated in
the literature, it is important that we improve our understanding
of the interaction of these factors to inform future attempts to
translate potential treatments into the clinic.
MATERIALS AND METHODS
Animals
Young (aged 8–10 weeks) and aged (aged 11 to 12 months)
male and female mice, expressing all six isoforms of human
tau (hTau) on a C57BL/6 and null murine tau background
(Jackson Laboratories, Bar Harbor ME), were housed singly
under standard laboratory conditions (23◦C ± 1◦C, 50 ± 5%
humidity, and 12-h light/dark cycle) with free access to food
and water throughout the study. All procedures were carried out
under Institutional Animal Care and Use Committee approval
and in accordance with the National Institutes of Health Guide
for the Care and Use of Laboratory Animals.
Injury Groups and Schedule
Forty-eight young and 52 aged hTau mice were randomly
assigned to TBI or sham conditions (unless otherwise noted,
young male TBI n = 11, young female TBI n = 12, young
male sham n = 11, young female sham n = 11, aged male TBI
n = 11, aged female TBI n = 14, aged male sham n = 12, aged
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female sham n = 16). Histochemical studies were performed
with n = 4 per group (male TBI, female TBI, male sham, female
sham, for both aged and young mice). Mice assigned to repetitive
mild TBI (r-mTBI) conditions received five injuries over a 9
day period, with an inter-injury interval of 48 h. Sham (r-sham)
animals underwent anesthesia as per their r-mTBI counterparts
(frequency and exposure time), but were not exposed to
injury.
Injury Protocol
Mice were subjected to closed, mild TBI as previously described
(Mouzon et al., 2012). Mice were anesthetized with 1.5 l/min
of oxygen and 3% isoflurane prior to mTBI. The top of the
head was then shaved for both sham and TBI animals, followed
by transfer to a stereotaxic frame (Just For MiceTM Stereotaxic,
Stoelting, Wood Dale, IL). Animals were placed on a heating
pad to maintain body temperature at 37◦C. A 5mm blunt metal
FIGURE 1 | Effect of repetitive mild traumatic brain injury (r-mTBI) on rotarod performance in (A) young and (B) aged hTau mice. Values were recorded with a total of 4
trials within a week after the last injury/anesthesia with three 5min accelerating trials. Results are the mean ± SEM of the time animals remained on the rotarod before
falling and normalized to baseline. There was no impairment with multiply injured animals in young male and female between days 1 and 7 of testing after last mTBI or
anesthesia (p > 0.05). In the aged cohort, Female TBI mice performed worse than their sham counterparts (p < 0.001) and worse than the male r-mTBI group
(p < 0.001) on all days of Rotarod testing. *p < 0.05.
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impactor tip was retracted and positioned midway relative to
the sagittal suture before each impact. The injury was triggered
using the myNeuroLab controller at a strike velocity of 5 m/s,
strike depth of 1.0mm, and dwell time of 200 milliseconds. The
impact occurred over intact skin and produced no skull fractures,
hematomas, or other gross signs of pathology. No mortality
was observed with these mice during these experiments. At
the end of the procedure, each animal was removed from the
stereotaxic table, allowed to recover on a heating pad and,
becoming ambulatory, was returned to its home cage. To control
for the effects of repeated anesthesia sham animals underwent
the same procedures and were exposed to anesthesia for the same
length of time as the mTBI animals, but did not receive a hit.
Neurobehavior
Experimenters were blinded to group assignments during all
neurobehavioral testing. Rotarod testing was performed as
previously described with modifications (Mouzon et al., 2012).
One day of pre-training and baseline testing was performed on
the day prior to the start of the injury or sham procedure. All mice
were given 3 trials to acclimate to the Rotarod at a constant speed
of 5 revolutions per minute (RPM). Following the acclimation
trials, the Rotarod was set to an accelerating speed of 5–50 RPM
over a period of 5min for baseline testing and post-injury testing.
One day after the administration of the last r-mTBI or r-sham
procedure, Rotarod testing was resumed. Mice were then tested
every other day after surgery starting on day 1 and ending on day
7 (total of 4 trials), at an accelerating speed of 5–50 RPM over a
period of 5min. Three trials were given with a 3min rest period
between trials. Latency to fall and the speed of the Rotarod at the
moment of the fall was recorded for each trial and the latency to
fall was averaged within each day. The post-baseline daily latency
to fall averages were then reported as a proportion of baseline.
Descriptive statistics, including means and standard errors, were
calculated from the percent baseline fall latency times for each
group and sex at each post-baseline study time for both young
and aged mice. Separately for young and aged mice, the Rotarod
data were fit to the following linear mixed model:
Fall Latencyijk = µ+ groupi + sexj + groupi ∗ sexj + εijk
where µ is the overall mean percent baseline fall latency time,
groupi is the effect of the ith group (i=mTBI or Sham), sexj
is the effect of the jth sex (j=female or male), groupi ∗ sexj is
the interaction effect between groupi and sexj, and εijk is the
leftover difference of the kth subject that is unexplained by the
model. In addition to these model terms, an auto-regressive
[AR(1)] repeated measure for study day within an animal was
included such that multiple trials on the same mouse were
FIGURE 2 | (A) Evaluation of spatial memory retention (probe) using the Barnes maze on days 8–14 after last mTBI in young mice. (B) Survival analysis chart of the
time to find the target hole in the Barnes maze probe trial. (C) Evaluation of spatial memory retention (probe) using the Barnes maze on days 8–14 after last mTBI in
aged mice. (D) Survival analysis chart of the time to find the target hole in the Barnes maze probe trial. Bars represent standard error but are biased by ceiling effects
within the data.
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considered together and correlated with respect to time and not
independently. This model was used to estimate the size and
significance of the difference in average percent baseline fall
latency between injury groups (both overall and within sex) and
between sexes (both overall and within injury group).
Following Rotarod, Barnes maze testing was administered
as previously described immediately after the first rotarod test
(Mouzon et al., 2012). Each mouse was given 90 s to explore the
maze and enter the goal box. On the 7th day the goal box was
removed and the mouse was given a 60 s probe trial starting in
the center of the table. Each mouse’s orientation and movement
was recorded by Noldus Ethovision XT software. The primary
outcome in the Barnes maze data is time (in seconds) to reach the
goal box. The effects of interest in this analysis were once again
sex, injury group (TBI vs. Sham), and their interaction.
Since time-to-target data tends not to be normally distributed
and contains ceiling effects from mice reaching the maximum
trial time, the behavioral outcome was evaluated using survival
analysis methods. Here, survival time, or equivalently event time,
is the time (in seconds) to reach the goal box. Comparisons of
event time distributions are superior to comparisons of event
rates in the presence of censoring, and they have the added
advantage that they are sensitive to differences in both the time
to event as well as the overall percentage of events between
groups.
For both young and aged mice, the event time distributions
(proportion of animals in each group that have not reached
the target hole at any given time) and median time-to-target
were estimated within sex and injury group using Kaplan-Meier
methods. The median time-to-target is the time at which half
of the animals have reached the goal box. For time-to-target
data, the median is preferred to the mean for two reasons: (1)
censoring biases the mean and (2) time-to-target data tends not
to be normally distributed.
Next, the Cox proportional hazards regressionmodel was used
to test the effects of sex, injury group, and their interaction on
time to reach the goal box for young and aged mice separately.
The sex by injury group interaction effect, the main effects of
FIGURE 3 | Amyloid Precursor protein (APP) immunohistochemistry of sagittal sections of the mouse brain at ± 0.4mm lateral to midline in the corpus callosum in
female (A–D) and male (E–H). Black box (I) indicates the area of interest shown at higher magnification (A–H) in a sagittal section of a mouse brain. Tissue staining
from young and aged sham (A,C,E,G) was negative for APP immunostaining. Immunoreactive axonal profiles were observed as discrete axonal profiles in the corpus
callosum of all injured animals (B,D,F,H). The number of APP-positive profiles was greater in young vs. aged mice among females (p < 0.01) and overall (averaged
over sex, p < 0.001) (J,K). The interaction between age and sex was not significant. ***p < 0.0001.
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sex and injury group, and the effect of injury group within sex,
and sex within injury group were also tested. Wald chi-square
test statistics were used to evaluate the significance of model
parameters. For a single degree-of-freedom hypothesis (TBI vs.
sham), the Wald chi-square test statistic reduces to a standard
normal deviate, or the regression coefficient estimate divided by
its standard error. The estimated hazard ratio is computed by
exponentiating the regression coefficient for the group effect, and
it loosely represents the relative risk of reaching the goal box at
any given time in the TBI vs. sham group. Values <1 indicate
longer times to reach the goal box in the TBI group vs. the sham
group.
Histology
All mice were euthanized 15 days after the last mTBI/sham
injury by anesthetizationwith isoflurane, followed by transcardial
perfusion with heparinized PBS (pH 7.4) and then by PBS
containing 4% paraformaldehyde. After perfusion, brains were
post-fixed in 4% paraformaldehyde (4◦C) for 48 h. Brains were
then blocked paraffin embedded using Tissue-Tek VIP (Sakura,
USA), cut at 6µm on a 2030 Biocut microtome (Reichert/Leica,
Germany) andmounted on positively charged glass slides (Fisher,
Superfrost Plus). Prior to staining, sections were deparaffinized
in xylene, and rehydrated in an ethanol to water gradient.
Slides were analyzed under bright field microscope (BX60,
Leica, Germany) and digital images visualized and acquired
using a MagnaFire SP camera (Olympus, Tokyo, Japan). Sets
of adjacent sections were stained for glial fibrillary acid protein
(GFAP, 1:20,000; Dako, Glostrup, Denmark, ZO334), ionized
calcium binding adaptor molecule 1 (Iba1. 1:5000; Abcam,
Cambridge, MA, ab5076), or amyloid precursor protein (APP,
1:40,000; Millipore, Billerica, MA, MAB348). As a negative
control, a single section was processed for immunostaining
with the exception of the primary antibody. Tissue sections
FIGURE 4 | Glial fibrillary acid protein (GFAP) immunohistochemistry of sagittal sections of the mouse brain at ± 0.4mm lateral to midline in the corpus callosum in
male (A–D) and female (E–H). Black box (I) indicates the area of interest shown at higher magnification (A–H) in a sagittal section of a mouse brain. Healthy astrocytes
with quiescent morphology were observed in sham animals in both young and aged mice. The average percent area for the r-mTBI group was greater compared to
the sham control group for females (averaged over age, p < 0.0001), males (averaged over age, p < 0.0001), aged (averaged over sex, p < 0.0001), young (averaged
over sex, p < 0.0001), and overall (averaged over sex and age, p ≤ 0.0001) (J,K). Additionally, the average percent area for the young mice was lower compared to
the aged mice for females (averaged over injury group, p = 0.0423) and overall (averaged over sex and injury group, p = 0.0077). Tissue sections were counterstained
with hematoxylin. ***p < 0.0001.
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were subjected to antigen retrieval with either heated tris-
ethylenediaminetetraacetic acid (EDTA) buffer (pH-8.0) or
modified citrate buffer (Dako, Glostrup, Denmark, S1699)
under pressure for 7min. Endogenous peroxidase activity was
quenched with a 15min H2O2 treatment (3% in water).
Tau immunohistochemistry was performed using the following
monoclonal antibodies at a 1:500 dilution: AT8 [Ser202, Thr
205] (ThermoFisher Scientific, Waltham, MA MN1020), CP13
[pS202]; PHF1 [pS396/404]; RZ3 [pThr231]. CP13, PHF1, and
RZ3 generously provided by Dr. Peter Davies, The Feinstein
Institute for Medical Research, Bronx, NY. Each section was
rinsed and incubated with the appropriate blocking buffer
(ABC Elite kit, MOM kit, Vector Laboratories, CA) for 20min,
before applying the appropriate primary antibody overnight
at 4◦C. Then, the diluted biotinylated secondary antibody
from the ABC Elite Kit was applied. Antibodies were detected
using the avidin-peroxidase complex, after incubation with the
chromogen 3,3-diaminobenzidine (DAB) peroxidase solution
(0.05% DAB−0.015% H2O2 in 0.01M PBS, pH 7.2) for 6–7min
and counterstained with hematoxylin. Immunofluorescence was
performed with antibodies for the microglial marker Iba1
(1:300), astrocyte marker GFAP (1:5000), and Phospho-syk
[Tyr525/526, (1:200) Antibody #2711, Cell Signaling]. Prior to
immunostaining, samples were deparaffinization in xylene and
rehydration in ethanol solutions of decreasing concentrations
(2 × 100%, 95%, 70%). Antigen retrieval was performed by
heating slides in a citric acid buffer (Dako, Glostrup, Denmark,
S1699) under pressure, washed with PBS and transferred into
a Sudan black solution (15min) to inhibit autofluorescence.
Before primary antibody treatment slides were blocked for 1 h
with 10% donkey serum. Primary antibodies for Iba1, GFAP,
PSyk were applied on the slides and left overnight at 4◦C.
The next day, secondary antibodies Alexa488, Alexa568 and
Alexa647 were applied for PSyk, Iba1, and GFAP, respectively.
Slides were cover slipped with ProLong Gold Antifade DAPI
Mount.
FIGURE 5 | Immunohistochemical labeling for microglia with anti-Iba1. Sagittal sections of the mouse brain at ± 0.4mm lateral to midline in the corpus callosum in
female (A–D) and male (E–H). Black box (I) indicates the area of interest shown at higher magnification (A–H) in a sagittal section of a mouse brain. Black lines
indicate the approximate boundary of the corpus callosum body within each image. There was no microglial activation in the sham groups (A,C,E,G). An increased
area of anti-Iba1 immunoreactivity was observed in the corpus callosum at 15 days post r-mTBI in young and aged animals (B,D,F,H). The average percent area for
the young mice was lower compared to the aged mice (averaged over injury and sex, p < 0.05, J,K). Additionally, the average percent area for the young mice was
lower compared to the aged mice for males (averaged over injury group, p < 0.05; J,K). ***p < 0.0001.
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TABLE 1 | Summary of GFAP and Iba1 quantification.
Age of Mice Gender Treatment Group Mean Percent Area
(Std. Error)
GFAP Young Sham (Control) Female 3.35 (0.41)
Male 3.05 (0.90)
mTBI Female 11.18 (2.21)
Male 14.32 (1.26)
Aged Sham (Control) Female 4.50 (0.92)
Male 6.31 (0.94)
mTBI Female 16.13 (1.80)
Male 16.09 (1.90)
Iba1 Young Sham (Control) Female 2.65 (0.34)
Male 2.21 (0.36)
mTBI Female 11.92 (1.16)
Male 9.51 (0.65)
Aged Sham (Control) Female 4.28 (0.37)
Male 3.34 (0.31)
mTBI Female 10.56 (1.39)
Male 12.76 (1.85)
Immunohistochemical Quantification
Mice from both age groups were euthanized 15 days post-injury.
For each animal, sets of sagittal (n = 4) sections were stained
and analyzed by an observer blinded to experimental conditions
using ImageJ software (US National Institutes of Health,
Bethesda, MD). Using this software, images were separated
into individual color channels (red hematoxylin counter stain
and DAB brown chromagen) using the color deconvolution
algorithm. Three non-overlapping areas of 100 µm2 from each
of two sagittal sections in the corpus callosum (CC) were
randomly selected within which the area of GFAP or Iba-1
immunoreactivity was calculated and expressed as a percentage
of the field of view. The numbers of APP-positive profiles were
counted in three non-overlapping areas of 100 µm2 within
the CC.
The immunohisotochemical outcomes were percent area of
GFAP and Iba-1 and the number of APP-positive profiles. The
effects of interest in this analysis were sex, injury group (mTBI
vs. sham), age (young v aged), and their interactions. Descriptive
statistics, including means and standard errors, were calculated
from the percent area of GFAP and Iba-1 measurements for each
age, injury group, and sex. Average percent areas were calculated
within an animal (across sections), prior to calculating age,
injury group, and sex averages and standard errors. Descriptive
statistics, including medians and 25th and 75th percentiles, were
calculated from the number of APP-positive profiles for each
age, injury group, and sex. The raw percent area data were
assessed for normality using the Shapiro-Wilk test as well as
four alternative transformations (square-root, base-10 logarithm,
logit, and arcsine square-root). The transformation that closest
approached normality was used for all subsequent analysis.
Separately for GFAP and Iba-1, the percent area data was fit with
the following mixed ANOVAmodel:
Percent Areaijklm = µ+ agei + groupj + sexk + agei ∗ groupj
+ agei ∗ sexk + groupj ∗ sexk + agei ∗ groupj
∗ sexk + εijkl
where µ is the overall mean percent area, agei is the effect of the
ith age (i = Young or Aged), groupj is the effect of the jth group
(j = mTBI or sham), sexk is the effect of the kth sex (k = female
or male), agei ∗ groupj is the interaction effect between agei and
groupj, agei ∗ sexk is the interaction effect between agei and sexk,
groupj ∗ sexk is the interaction effect between groupj and sexk,
and agei ∗ groupj ∗ sexk is the interaction effect between agei,
groupj, and sexk. The εijkl term represent the leftover difference
of the lth observation of agei, groupj, and sexk that is unexplained
by the model. In addition to these model terms, a random
variance component for mouse was included such that multiple
observations on the same mouse were weighted together and
not individually. This model was used to estimate the size and
significance of the difference in percent area between ages, injury
groups, and between sexes.
For the APP data, no APP positive profiles were detected in
any of the sham animals. As a result, the analysis for these data
was subset to the mTBI injury groups. Analysis of the number
of APP-positive profiles determined using the following Poisson
regression model:
Number of APP − positive profilesiklm = µ+ agei + sexk + agei
∗ sexk + εikl
whereµ is the overall rate of the number of APP-positive profiles,
agei is the effect of the ith age (i=Young or Aged), sexk is
the effect of the kth sex (k=female or male), and agei ∗ sexk
is the interaction effect between agei and sexk. The εijkl term
represent the leftover difference of the lth observation of agei,
groupj, and sexk that is unexplained by the model. In addition
to these model terms, a random variance component for mouse
was included such that multiple observations on the same mouse
were weighted together and not individually. This model was
used to estimate the size and significance of the difference in
the number of APP-positive profiles between ages and between
sexes. All statistical analysis of the immunoreactivity data was
performed using SAS (ver. 9.4) and all results are reported using
the 0.05 level of significance.
RESULTS
Neurobehavior
Motor function was evaluated 24 h following the last
mTBI/anesthesia (Figure 1). Neither young male or female
mice had sensorimotor deficits by the end of the trials (male
r-sham 132 ± 10%; vs. male r-mTBI 124 ± 11%; and female
r-sham 115 ± 17%; vs. female r-mTBI 104 ± 12% on day 7).
However, in the aged cohort, female r-mTBI mice showed
shorter Rotarod fall times when compared to their female sham
counterparts (female r-sham 137± 10%; vs. female r-mTBI 87±
10%; p < 0.001 on day 7) and performed worse than their male
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FIGURE 6 | Immunohistochemical assessment of soluble phosphorylated tau pSer-202 (CP13) at approximately 0.5mm lateral to midline in the CA1 region of the
hippocampus (A–H) and in the neocortex (I–P) at 15 days after injury in young and aged female and male mice. Qualitatively, the r-mTBI group showed greater
dendritic and membranous staining in both the CA1 (arrows in C,D,G,H) and cortical neurons (arrows in J,L,N,P) when compared to their respective shams. In in the
aged group, intraneuronal immunoreactivity for CP13 was generally more intense within the perikarya and proximal apical dendrite of neurons in the hippocampal CA1
field of the male r-sham group (F). In addition, regardless of their sex and aged, some of the injured mice showed more intense CP13 immunoreactivity in long
dendritic process when compared to their respective sham (Q).
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r-mTBI counterparts (female r-mTBI 87 ± 10%; vs. male r-mTBI
152± 17%; p< 0.001 on day 7).
Cognitive deficit at 15 days post-last mTBI/anesthesia was
evaluated with the Barnes Maze behavioral test. The probe trial
analysis of the average time to reach the target zone, (defined by
the target escape hole and its adjacent north and south holes)
revealed that the performance of the young r-mTBI mice was
markedly impaired compared to the sham group when data are
combined across sexes (Figure 2, p < 0.02). Results of fitting
the Cox proportional hazards model indicated no interaction
between sexes and injury group (p = 0.776), and no sex effect
(p= 0.726).
For aged mice, the median time to reach the target hole was
also lengthened in the r-mTBI group compared to the r-Sham
group for females (p < 0.004) and for both sexes combined
(p = 0.001). Results of fitting the Cox proportional hazards
model indicated no interaction between sexes and injury group
(p= 0.499), and only a marginal effect of sex (p= 0.063).
APP Immunostaining
APP-immunoreactive axonal profiles, a marker of axonal injury,
were observed 15 days post-injury in the corpus callosum
(CC) (Figure 3I) of both young and aged r-mTBI groups
(Figures 3B,D,F,H) but not in their controls (Figures 3A,C,E,G).
These APP immunoreactive axonal profiles were observed
as small, granular immunoreactive profiles within the CC
(Figure 3). There were no APP-positive profiles observed in the
Sham animals. Analysis found that the number of APP-positive
FIGURE 7 | Immunoblots of cortical brain extracts of mice probed with monoclonal antibody CP-13 (pS202/pT205), PHF1, (pS396/404) or β-actine at 15 days
post-injury in young (left panels) or aged animals (right panels). For the CP13 data (A), there were no difference observed between gender, age, or treatment (*,
p > 0.05). For the PHF1 data (B), the average percent of PHF1 for the young mice was lower compared to aged mice averaged over gender and treatment
(p < 0.0001) as well as within female mice (averaged over treatment, p = 0.0362), within male mice (averaged over treatment, p < 0.0001), within the mTBI treatment
group (averaged over gender, p = 0.0024), and within the sham treatment group (averaged over gender, p = 0.0015). Additionally, the average percent of PHF1
among female mice was lower compared to the male mice averaged within the mTBI treatment (averaged over age, p = 0.0244). All densitometry values for CP13,
PHF1, DA9 for individual bands were normalized to the beta actin (β-actin) value for their respective lane and this ratio used for statistical analysis. The primary
outcomes in the Western Blot analysis were the percent of CP13 and PHF1 antibodies relative to the total (DA9). N = 4 (injured/sham). *p < 0.05; ***p < 0.0001.
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profiles was significantly greater in young vs. aged mice among
females (p = 0.0016) and overall (averaged over gender, p =
0.0005), but the effect was only marginally significant among
males (p = 0.0643) (Figures 3J,K). The interaction between
age and gender was not significant, which indicates that age
effects can be combined across genders and gender effects can be
combined across ages. There were no significant gender effects
detected.
GFAP Immunostaining
The effect of mTBI and sex on astroglial activation was
evaluated at 15 days post-injury in both young and aged
animals in the body of the CC (Figure 4I). For mice subjected
to r-mTBI, immunostaining for GFAP revealed evidence of
a reactive astrogliosis in the CC of both aged groups
(Figures 4B,D,F,H; p < 0.0001). Astrocytes with quiescent
morphology were observed in sham animals at both time points
(Figures 4A,C,E,G). No sex effect was observed among the sham
or injured groups at 15 days post-injury (p> 0.05). Additionally,
the average percentage area of astroglial activation for the young
mice was lower compared to the aged mice for females (averaged
over injury group, p < 0.05) and overall (averaged over sex and
injury group, p< 0.05) (Figures 4J,K).
Iba1 Immunostaining
The pattern and distribution of activated microglia revealed in
staining for Iba-1 was similar to GFAP. In the sham animals,
none of the regions of interest showed cells with structural
characteristics of activated microglia (hypertrophic and bushy
morphology); (Figures 5A,E,C,G; p > 0.05). However, in the
CC (Figure 5I), the r-mTBI mice showed a notable increase
in Iba1-immunoreactivity with clusters of activated microglias
(Figures 5B,F,D,H; p < 0.0001). Additionally, the average
percent area of Iba1-immunoreactivity for the young mice was
lower compared to the aged mice for males (averaged over injury
group, p< 0.05), young sham mice were significantly lower than
the aged sham group (averaged over sex, p < 0.05), and overall
(averaged over sex and injury group, p < 0.05) (Figures 5J,K).
There were no sex effects detected (p > 0.05). The quantification
of GFAP and Iba1 immunostaining is summarized in Table 1.
Tau Immunohistochemistry
To investigate the effect of TBI on tau in this model, we
performed immunohistochemical analyses using CP13, RZ3,
AT8, and PHF1 (an antibody that recognizes early tau pathology).
Immunohistochemical analyses revealed no sex or aged effect
in the localization or accumulation for the p-tau epitopes CP13
and RZ3. However, all injured groups exhibited somatodendritic
accumulation of CP13 immunoreactivity in the hippocampal
subfields CA1 (see Figures 6A–H), and CA3 (data not shown) as
well as in the neurons in the superficial layer of the cerebral cortex
(see Figures 6I–P). Additionally, intense dendritic staining was
noticed in some injured mice regardless of sex or age (see
Figure 6Q). Interestingly, intraneuronal CP13 immunoreactivity
in aged male sham mice was generally more intense than the
aged females but only in the CA1 subregion of the hippocampus.
The same brain region was devoid of neurons positive for RZ3,
PHF1, and AT8 regardless of the injury status (see Supplemental
Figure 1).
For the CP13 western blot data, there were no significant
differences observed in the percent of total data between
treatment, gender, or age nor were any interactions between age,
treatment group, or gender detected. For the PHF1 western blot
data, significantly lower percent of total values were observed
FIGURE 8 | Immunohistochemical labeling for P-SYK, anti-Iba1 and GFAP. Sagittal sections of the mouse brain at ± 0.5mm lateral to midline in the corpus callosum
in aged male animal (A–H). Sham mice show an absence of P-SYK immunoreactivity (green fluorescent signal) in the corpus callosum (A–D) whereas r-mTBI mice
demonstrate the presence of activated SYK (E–H) in microglia (white arrow, F). Of note, GFAP and Iba-1 immunoreactivity is increased in r-mTBI compared to sham
mice revealing astrogliosis and microgliosis.
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in the young mice, compared to aged mice, within both
treatments, within both age groups, and averaged over treatment
and age (Figure 7). Additionally, significantly lower percent of
total values were observed in female mice, compared to male
mice, within the mTBI treatment group, within aged mice, and
averaged over age and treatment. No interactions between age,
treatment group, or gender were detected in the PHF1 data.
Phospho Syk Immunohistochemistry
Our previous work on Alzheimer Disease (AD) demonstrated
that Syk regulates Tau phosphorylation by controlling the
activation of glycogen synthase 3β (Paris et al., 2014), thus
sections were immunostained for p-Syk. At 15 days post-injury
we observed in both young and aged injured animals an increase
of p-Syk immunoreactivity in activated microglia within the
corpus callosum regardless of their sex (Figure 8), while p-Syk
immunoreactivity was absent in their respective shams.
DISCUSSION
In the current study, we have examined the effect of sex on
neurobehavioral and pathological outcomes in young and aged
hTau mouse after repetitive mild TBI. Our results demonstrate
that young (aged 8–10weeks) animals exposed to r-mTBI have
short-term behavioral abnormalities that manifest as impaired
spatial memory, but no deficits in motor function. The injury
used in the experiment is mild in nature, producing no skull
fracture, bleeding, or other gross pathology and requires minimal
time under anesthesia since no incision is necessary. No sex-
specific effects were observed during neurobehavioral testing
of young animals. In contrast, in aged animals we observed
impaired motor coordination in the Rotarod task and spatial
memory in the Barnes maze task exclusively in female TBI mice,
in keeping with an age-dependent effect of sex on outcomes from
r-mTBI in this model.
In the Rotarod test, aged female mice exclusively exhibited
impaired motor performance after TBI. This effect does not
appear to correlate with either the neuroinflammatory nor the
tau pathology seen in these animals, but may be driven by effects
in the vestibular nuclei that we have yet to be investigated.
Future studies will examine additional pathological markers
across additional brain regions and at additional time points
post-injury, to better understand these sex-specific differences in
the response to TBI in the aged brain. Relevant TBI-dependent
pathologymay reside, for instance, in regions of the basal ganglia,
not yet analyzed, and may require analysis of markers not yet
employed by our studies. For example, Uryu and colleagues have
previously reported transient increases in synuclein pathology
that were specific to aged mice, with increases in alpha and
beta synuclein present 1 week following TBI with antibodies
for conformationally altered and nitrated both showing positive
staining within the striatum (Uryu et al., 2003). Peripheral
nervous system deficits may also be a contributing factor in these
results; TBI is known to be associated withmotor neuron disease-
like peripheral pathology (Wright et al., 2016) and mild closed
head injury has been shown to exacerbate rotarod deficits and
increase markers of denervation in a G93A transgenic mouse
model of ALS (Evans et al., 2015). Although sex-differences
have not been shown as a factor in these studies, our findings
suggest that it may be an important area for future studies to
examine.
Neurobehavioral testing of spatial memory did not show
any sex-dependent effects of TBI in young mice, where TBI
impaired the spatial memory of male and female mice equally
at 15 days post-injury, but in the aged mice a TBI-dependent
effect on Barnes maze testing was specific to female mice. The
absence of a TBI effect in the male mice was driven by worsened
performance of male sham mice. To our knowledge, this age and
sex-dependent effect on Barnes maze spatial memory has not
been previously reported in hTau mice (P. Davies, pers. comm.).
Aged male sham, male TBI, and female TBI mice all exhibited
qualitatively higher levels of perikaryal tau immunoreactivity by
CP13 in the hippocampus than female sham mice, potentially
explaining the differences in spatial memory that we observed in
these aged mice.
Young hTau mice exhibited a pronounced r-mTBI dependent
astroglial/microglial activation in the corpus callosum of both
male and female htau mice, indicating no sexual dimorphism for
the glial response at 15 days post-injury. The effect of sex and
age on white matter degeneration was similar among all groups
suggesting that male and females may be equally susceptible to
axonal injury. While multiple reports have noted that female
rodents appear to be protected against the acute CNS trauma
and stroke (Roof and Hall, 2000b; Dang et al., 2011; Wright
et al., 2011), we report no effect of sex on the glial response
or axonal transport interruption in our study. In contrast, our
data are in agreement with the recent study of Villapol et al,
where female mice are acutely more resistant to moderate to
severe TBI compared with male mice during the acute and
subacute phase (3–7 days) post-injury but comparable to their
male counterpart at 30 days post-injury (Villapol et al., 2017).
Future studies will be conducted to determine if there are any
sex-dependent histological differences in these hTau mice at
shorter post-injury timepoints. We further report that, while
no sexual dimorphism was observed in tau pathology in the
young animal, a trend for an increased phopho tau pathology
in neuronal cell body and somatodendritic compartments of the
aged sham male comparable to the injured animals. Western
blots showed no sexual dimorphism in the cortical levels of
CP13 in young or aged mice, but did reveal significantly lower
PHF1 levels in aged female TBI mice compared to male TBI
mice, validating sexual dimorphisms of phospho tau levels in
these mice. While more studies are required to establish whether
an increase of CP13 in the underlying hippocampal region
and PHF1 in the cortex can be harnessed to worse cognitive
outcome, this is the only observation that corroborates with
the impaired performance of the aged male sham group. This
observation is supported by data from Rubenstein et al also
using a model of closed head injury in mice, suggesting that
there is a link between cognitive dysfunction and an increase
of p-tau (Rubenstein et al., 2017). The tyrosine kinase Syk
is known to phosphorylate tau (Lebouvier et al., 2008) and
in this study we have found phosphorylated Syk exclusively
in TBI mice colocalized with Iba1. In this study, microglial
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Iba1 pathology associated with injury and age, but no sexual
dimorphisms were observed and are unlikely to be the source of
the differential phospho tau levels seen in our male and female
mice.
While the reduced tau pathology and improved spatial
memory of aged female shammicemay suggest a neuroprotective
role of female sex, this effect appears to be limited to the
age-dependent tau pathology and does not protect against
TBI-dependent alterations. Additionally, TBI-dependent motor
deficits observed in Rotarod testing of aged female hTau
mice demonstrates that the neuroinflammatory and phospho-
tau markers examined in the cortex, corpus callosum, and
hippocampus as part of this study do not provide a complete
picture of TBI-dependent deficits which may be mediated by
additional cortical or vestibular changes we have yet to examine.
In humans, both peripheral and central damage to the vestibular
system is known to occur at various injury levels and produces
some of the most common side effects of mild TBI, including
dizziness and disruptions to coordinated eye movement (Gizzi
et al., 1996; Balaban et al., 2016;Wallace and Lifshitz, 2016; Hoffer
et al., 2017). Although most pathology seen in our model of
r-mTBI was localized to the corpus callosum, we saw no effect
of sex on any of the markers under analyses. Damage to the
vestibular system, whether central or peripheral, is far less studied
in the pre-clinical literature, though it has been previously
discussed as a source of TBI-dependent differences in rotarod
performance, and transient increases in glucose metabolism has
been observed in the vestibular nuclei after blast TBI in rats
(Awwad et al., 2015; Guley et al., 2016).
In this study, we have found age-dependent sex-specific
differences in the response to repetitive mild TBI in hTau
transgenic mice. Young mice exhibited no sex-dependent
differences in behavioral or pathological outcomes at 15 days
post-injury. However, aged female mice revealed worse motor
outcome after injury compared to males, independent of
neuroinflammatory or tau pathology. Conversely, the Barnes
maze impairments and increased tau phosphorylation found in
aged male mice shows a potential correlation between spatial
memory and age-dependent phospho tau pathology. These
findings underscore the need for further study of how sex-
dependent effects of TBI change with age, and it is important
to note that the tau-centric nature of the sexual dimorphisms
of our findings suggest that these results may be specific to the
hTau mice used. There is a pressing need for additional studies
both pre-clinically and clinically to understand how these factors
influence TBI outcomes, and to improve our understanding of
sex-dependent TBI outcomes in additional mouse strains and
genotypes, including wild type animals which may not exhibit
these effects. Preclinical models need to adequately study the
variables influencing TBI-pathogenesis in order to effectively
serve as platforms for discovery and development of therapeutics,
and our data suggest that sex-dependent effects on cognition
with aging and TBI may be driven in part by differences in
sex-dependent tau phosphorylation.
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